nnc 711 has been researched along with flunitrazepam in 1 studies
| Studies (nnc 711) | Trials (nnc 711) | Recent Studies (post-2010) (nnc 711) | Studies (flunitrazepam) | Trials (flunitrazepam) | Recent Studies (post-2010) (flunitrazepam) |
|---|---|---|---|---|---|
| 112 | 0 | 21 | 2,697 | 298 | 130 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosoi, R; Inoue, O; Kobayashi, K; Nakano, T; Nishimura, T; Wakahara, S; Watanabe, Y | 1 |
1 other study(ies) available for nnc 711 and flunitrazepam
| Article | Year |
|---|---|
Effects of the GABAergic system on in vivo binding of [3H]N-methylspiperone.
Topics: Animals; Brain; Cerebellum; Cerebral Cortex; Dopamine Agonists; Flunitrazepam; GABA Agonists; Male; Mice; Neostriatum; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Oximes; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA; Receptors, GABA-A; Spiperone; Tritium | 1998 |